Start by identifying the filler and the concern
Hyaluronidase is an enzyme used in aesthetic medicine to break down hyaluronic acid (HA) filler. The 2021 CMAC guidance discusses both planned correction and emergency use. That distinction is essential: a routine appointment about an unwanted appearance is different from a possible complication requiring immediate medical assessment.
Bring the original product name, treatment date, areas, amount if recorded, previous corrections and the treating clinic’s records if available. Describe what changed and when, including swelling, discomfort or a new lump. Photographs and memories can help explain the history but cannot reliably identify every material or establish the diagnosis.

Can every kind of filler be dissolved?
No. Hyaluronidase targets HA; it is not a universal method for removing all fillers. FDA patient guidance warns that removal or reduction may require injections, surgery or other interventions and may be difficult or impossible, especially with permanent or non-HA materials. Those interventions have their own risks.
If the original material is unknown, say so. Ask what further assessment is needed and whether records, imaging or specialist referral would help. Do not assume that a lump is simply excess filler or that immediate dissolving is appropriate. A delayed reaction, infection and a placement concern need different clinical evaluation.
| Bring or clarify | Why it matters |
|---|---|
| Original product and date | Helps establish which material may be present |
| Treatment and correction history | Explains previous exposure and what changed |
| Symptoms and timing | Helps distinguish a routine concern from a complication |
| Goal and limits | Clarifies whether reduction, further assessment or another approach is appropriate |
Which symptoms should not wait for a cosmetic booking?
FDA guidance advises immediate medical attention for unusual pain, vision changes, white, gray or blue skin near the injection site, or stroke-like symptoms during or shortly after filler injection. Do not wait for a planned overseas visit, an online message response or a routine dissolving appointment if those symptoms occur.
Breathing or swallowing difficulty or a severe allergic reaction also requires emergency help. This article is not a diagnostic tool or a self-treatment protocol. It deliberately does not provide a dose, dilution, injection location or emergency treatment sequence. Seek in-person medical care rather than trying to apply a professional protocol yourself.

What should the risk and allergy discussion cover?
Tell the clinician about previous hyaluronidase exposure, reactions to medicines, a history of severe allergy and reactions to bee or wasp stings. The CMAC paper discusses possible cross-reactivity and explains why history and clinical context matter. A routine skin test is not a universal guarantee that a serious reaction cannot occur.
Local pain, swelling, bruising, redness or itching can occur; allergy and a severe systemic reaction are also concerns to discuss. Ask which product is proposed, how the clinician assesses your history and what support is available if a reaction occurs. Do not arrange your own allergy test, buy an enzyme online or attempt an injection.
Understand the evidence and the limits of a correction
CMAC’s 2021 publication is clinical guidance, not a randomized trial proving a predictable result for every filler. It notes differences among HA products and inconsistent study findings. The amount, properties and location of material and the tissue response can affect management; repeat assessment or treatment may be needed.
Dissolving is not a guaranteed return to your earlier appearance. Swelling and the underlying tissues can affect what you see, and an unresolved concern may require another diagnosis or referral. The paper describes UK and US off-license use; that is not a statement of Korean approval status or of the particular product DI uses. Ask your clinician about the actual product and consent information applicable to your care.

What does DI’s published price include?
DI lists “Filler dissolution (hyaluronidase),” entry di-158, at KRW 120,000 in its price schedule dated 11 September 2026. VAT is excluded. The entry does not establish how much material you have, the medicine or amount needed, the number of visits, an emergency-care service or the final cost of an individual plan. Confirm current availability and scope with DI.
Request an itemized quotation after assessment. Ask about the consultation, medicines, any further investigation, repeat treatment and follow-up. If an urgent complication is suspected, seeking immediate medical care takes priority over comparing cosmetic prices or waiting to travel to a preferred clinic.
Plan review and travel around the assessment
Before a nonurgent visit, confirm the appointment, consultation fees and language or interpreter arrangements. DI is near Gangnam Station at 12F, Seosan Building, 441 Gangnam-daero, Seocho-gu, Seoul. Share the original filler records through the clinic’s agreed route, and ask which information is needed; an online inquiry does not confirm suitability or a treatment date.
Ask for written care instructions, whom to contact with a concern and how review will work after you leave Korea. Do not book a new filler injection or a fixed return flight based on a generic timing rule. Editorial sources checked 3 November 2026; no new clinician review is claimed. Illustrations are AI-generated education, not results or procedural instructions. #DIPlasticSurgery #FillerDissolving #Seoul
Information that helps us prepare a useful reply
When contacting the clinic, tell us the procedure or concern you would like to discuss, your preferred language, whether you have had related treatment before and the dates you could visit Seoul. International patients may also wish to include their arrival and departure dates so the team can explain when an in-person consultation and follow-up may fit into the trip.
Please do not send passport numbers, payment information or complete medical records through an initial website inquiry. A coordinator can explain which health information or photographs are relevant and how they should be shared. Online guidance is preliminary; suitability, technique and the final treatment plan are determined only after an appropriate medical assessment.
